CME Group Inc. $CME Stock Position Boosted by Meeder Asset Management Inc.

Meeder Asset Management Inc. increased its position in shares of CME Group Inc. (NASDAQ:CME – Free Report) by 228.5% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 25,193 shares of the financial services provider’s stock after buying an additional 17,525 shares during the period. Meeder Asset Management Inc.’s holdings in CME Group were worth $6,600,000 at the end of the most recent reporting period.

Several other hedge funds also recently added to or reduced their stakes in the stock. Bridgewater Advisors Inc. purchased a new position in shares of CME Group during the second quarter valued at approximately $612,000. Focus Financial Network Inc. bought a new stake in CME Group during the 3rd quarter valued at $1,513,000. The Manufacturers Life Insurance Company purchased a new stake in shares of CME Group in the 2nd quarter worth $53,671,000. Haverford Trust Co bought a new position in CME Group during the 2nd quarter worth about $13,818,000. Finally, Bowie Capital Management LLC bought a new position in shares of CME Group during the second quarter valued at approximately $22,991,000. 87.75% of the stock is owned by institutional investors and hedge funds.

CME Group Trading Down 0.4%

CME opened at $310.25 on Thursday. CME Group Inc. has a 52 week low of $218.31 and a 52 week high of $329.16. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. The business has a fifty day simple moving average of $288.15 and a 200-day simple moving average of $281.93. The firm has a market cap of $111.05 billion, a P/E ratio of 25.45, a P/E/G ratio of 3.80 and a beta of 0.15.

CME Group (NASDAQ:CME – Get Free Report) last released its earnings results on Wednesday, October 21st. The financial services provider reported $3.02 earnings per share for the quarter, beating the consensus estimate of $2.99 by $0.03. The company had revenue of $1.74 billion during the quarter, compared to the consensus estimate of $1.71 billion. CME Group had a return on equity of 16.23% and a net margin of 63.33%. CME Group’s revenue was up 10.6% compared to the same quarter last year. During the same period in the previous year, the company posted $2.68 EPS. On average, equities analysts expect that CME Group Inc. will post 12.35 earnings per share for the current year.

CME Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, December 30th. Investors of record on Friday, December 11th will be paid a dividend of $1.30 per share. The ex-dividend date is Friday, December 11th. This represents a $5.20 annualized dividend and a yield of 1.7%. CME Group’s payout ratio is presently 42.66%.

Analysts Set New Price Targets

Several research analysts recently weighed in on the company. Wells Fargo & Company boosted their target price on CME Group from $315.00 to $333.00 and gave the stock an “overweight” rating in a research note on Thursday, October 22nd. Bank of America lifted their price objective on shares of CME Group from $226.00 to $230.00 and gave the company an “underperform” rating in a report on Thursday, July 23rd. Piper Sandler reiterated an “overweight” rating and set a $330.00 price target (up from $295.00) on shares of CME Group in a research report on Thursday, October 22nd. UBS Group boosted their price objective on CME Group from $270.00 to $310.00 and gave the company a “neutral” rating in a research report on Thursday, October 22nd. Finally, Deutsche Bank cut shares of CME Group from a “buy” rating to a “hold” rating and dropped their price target for the company from $286.00 to $270.00 in a research note on Wednesday, August 19th. Ten investment analysts have rated the stock with a Buy rating, six have given a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat, CME Group has an average rating of “Hold” and an average target price of $314.44.

Get Our Latest Research Report on CME

Insider Buying and Selling

In related news, Director Howard Siegel sold 2,000 shares of the business’s stock in a transaction on Monday, November 2nd. The shares were sold at an average price of $303.00, for a total value of $606,000.00. Following the completion of the sale, the director directly owned 19,873 shares of the company’s stock, valued at $6,021,519. The trade was a 9.14% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Terrence Duffy sold 15,000 shares of CME Group stock in a transaction dated Thursday, September 10th. The stock was sold at an average price of $274.44, for a total value of $4,116,600.00. Following the sale, the chief executive officer owned 40,630 shares in the company, valued at $11,150,497.20. This trade represents a 26.96% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 33,511 shares of company stock valued at $9,714,580 over the last three months. 0.30% of the stock is currently owned by insiders.

CME Group Company Profile

(Free Report)

CME Group operates a global marketplace for derivatives and other financial products. Through its exchanges—CME, CBOT, NYMEX and COMEX—it offers futures and options contracts tied to interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The company also provides clearing and settlement services, market data and related products. Its electronic trading platform, CME Globex, supports access to its markets by participants around the world, alongside its open-outcry and privately negotiated trading services.

Further Reading

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.